Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors

Digestion

Volumn 62, Issue SUPPL. 1, 2000, Pages 19-26

  Rindi, Guido ^a,b   Villanacci, V ^a   Ubiali, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Anatomia Patologica 2 ^*  (Italy)

Author keywords

Electron microscopy; Endocrine cells; Gut; Hormones; Immunohistochemistry; Loss of heterozygosity; Molecular genetics; Pancreas

Indexed keywords

CANCER RISK; CONFERENCE PAPER; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PHENOTYPE; PRIORITY JOURNAL; TUMOR LOCALIZATION;

EID: 0033839495     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051851     Document Type: Conference Paper

References (65)

1. Solcia E, Capella C, Fiocca R, Sessa F, LaRosa S, Rindi G: Disorders of the endocrine system; in Ming SC, Goldman H (eds): Pathology of the Gastrointestinal Tract, ed 2. Philadelphia, Williams & Wilkins, 1998, pp 295-322.
2. Rindi G, Capella C, Solda E: Pathobiology and classification of digestive endocrine tumors; in Mignon M, Colombel JF (eds): Recent Advances in the Pathophysiology of Inflammatory Bowel Disease and Digestive Endocrine Tumors. Montrouge, John Libbey Eurotext, 1999. pp 177-191.
3. Hanahan D: Heritable formation of pancreatic B-cell tumors in transgenic mice expressing recombinant insulin simian virus 40 oncogenes. Nature 1985;315:115-122.
4. Efrat S, Teitelman G, Anwar M, Ruggiero D, Hanahan D: Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic alpha cells. Neuron 1988;1:605-613.
5. Rindi G, Grant SGN, Yiangou Y, Ghatei MA, Bloom SR, Bautch VL, Solcia E, Polak JM: Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice: Heterogeneity of hormone expression. Am J Pathol 1990;136:1364-1373.
6. Lopez MJ, Upchurch BH, Rindi G, Leiter AB: Studies in transgenic mice reveal potential relationships between secret in-producing cells and other endocrine cell types. J Biol Chem 1995; 270:885-891.
7. Bishop AE, Power RF, Polak JM: Markers of neuroendocrine differentiation. Pathol Res Pract 1988;183:119-128.
8. Bishop AE, Polak JM, Facer P, Ferri GL, Marangos PJ, Pearse AGE: Neuron specific enolase: A common marker for the endocrine cells and innervation of the gut and pancreas. Gastroenterology 1982;83:902-915.
9. Rode J, Dhillon AP, Doran JF: PGP 9.5: A new marker for human neuroendocrine tumours. Histopathology 1985;9:147-158.
10. Lloyd RV, Wilson BS: Specific endocrine tissue marker defined by a monoclonal antibody. Science 1983;222:628-630.
11. Rindi G, Buffa R, Sessa F, Tortora O, Solcia E: Chromogranin A, B and C immunoreactivities of mammalian endocrine cells. Distribution, distinction with the argyrophil component of secretory granule. Histochemistry 1986;85:19-28.
12. Jahn R, Schiebler W, Quimet C, Greengard P: A 38,000-dalton membrane protein (p.38) present in synaptic vesicles. Proc Natl Acad Sci USA 1985;82:4137-4141.
13. Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE: Synaptophysin: A novel marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA 1986;83: 3500-3504.
14. Buffa R, Rindi G, Sessa F, Gini A, Capella C, Jahn R, Navone F, De Camilli P, Solcia E: Synaptophysin immunoreactivity and small clear vesicles in neuroendocrine cells and related tumours. Mol Cell Probes 1988;1:367-381.
15. Erickson JD, Schäfer MKH, Bonner TI, Eiden LE, Weihe E: Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 1996;93:5166-5171.
16. Kolby L, Wangberg B, Jansson S, Forssell-Aronsson E, Erickson JD, Nilsson O: Gastric carcinoid with histamine production, histamine transporter and expression of somatostatin receptors. Digestion 1988;59:160-166.
17. Eissele R, Anlauf M, Schaler MK, Eiden LE, Arnold R, Weihe E: Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach. Digestion 1999;60428-439.
18. Rindi G, Paolotti D, Fiocca R, Wiedenmann B, Henry J-P, Solcia E: Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors. Virchows Arch 2000; 436:217-223.
19. Solcia E, Klöppel G, Sobin LH: Historical Typing of Endocrine Tumours. World Health Organization International Histological Classification of Endocrine Tumors, ed 2. New York, Springer. 2000.
20. La Rosa S, Sessa F, Capella C, Riva C, Leone S, Klersy C, Rindi G, Solcia E: Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 1996;429:323-333.
21. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, Stolte M, Capella C, Bordi C, Solcia E: ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysis. Gastroenterology 1999;116:532-542.
22. Chandrasekharrappa SC, Guru SC, Manickam P, Olufemi S-E, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal AK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ: Positional cloning of the gene of multiple endocrine neoplasia-type I. Science 1997;276:404-407.
23. Radford DM, Ashley SW, Wells SA Jr, Gerhard DS: Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia type 1. Cancer Res 1990;50:6529-6533.
24. Teh BT, Hayward NK, Wilkinson S, Woods GM, Cameron D, Sheperd JJ: Clonal loss of INT-2 alleles in sporadic and familial pancreatic endocrine tumors. Br J Cancer 1990;62:253-254.
25. Bale AE, Norton JA, Wong EL, Fryburg JS, Maton PN, Oldfield EH, Streeten E, Aurbach GD, Brandi ML, Friedman E, Spiegel AM, Taggart RT, Marx SJ: Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. Cancer Res 1991;51:1154-1157.
26. Beckers A, Abs R, Reyners E, De Boulle K, Steveanert A, Heller FR, Klöppel G, Meurisse M, Willems PJ: Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine ncoplasia type I syndrome. J Clin Endocrinol Metab 1994;79:1498-1502.
27. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharappa S, Guru SC, Manickam P, Olufemi S-E, Marx SJ, Spiegel AM, Collins FS, Liotta LA: Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 1996;56:5272-5278.
28. Eubanks PJ, Sawicki MP, Samara GJ, Wan Y-JY, Gatli RA, Hurwitz M, Passaro E Jr: Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus. Surgery 1997;173:518-520.
29. Debelenko LV, Zhuang Z, Emmert-Buck MR, Chandrasekharappa S, Manickam P, Guru SC, Marx SJ, Skarulis MC, Spiegel AM, Collins FS, Jensen RT, Liotta LA, Lubensky IA: Allelic deletions on chromosome 11q13 in multiple endocrine neoplasm type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 1997;57:2238-2243.
30. Chakrabarti R, Srivatsan ES, Wood TF, Enbanks PJ, Ebrahimi SA, Gatti RA, Passaro E Jr, Sawicki MP: Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13. Genes Chromosomes Cancer 1998;22:130-137.
31. Sawicki MP, Wan Y-JY, Johnson CL, Berenson J, Gatti RA, Passaro E Jr: Loss of heterozygosity on chromosome 11 in sporadic gastrinomas. Hum Genet 1992;89:445-449.
32. Eubanks PJ, Sawicki MP, Samara GJ, Gatti RA, Nakamura Y, Tsao D, Johnson C, Hurwitz M, Wan Y-JY, Passaro E Jr: Putative tumor suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. Am J Surg 1994;167:180-185.
33. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park W-S, Agarwal SK, Debelenko LV, Rester MB, Guru SC, Manickam P, Olufemi S-E, Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ, Emmert-Buck MR, Spiegel AM, Chandrasekharappa S, Collins FS, Burns AL, Marx SJ, Jensen RT, Liotta LA, Lubensky IA: Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 1997;57:4682-4686.
34. Beghelli S, Pelosi G, Zamboni G, Falconi M, Iacono C, Bordi C, Scarpa A: Pancreatic endocrine tumors: Evidence for a tumor suppressor pathogenesis and for a tumor suppressor gene on chromosome 17p. J Pathol 1998;186:41-50.
35. Fuji T, Kawai T, Saito K, Hishima T, Hayashi Y, Imura J, Hironaka M, Hosoya Y, Koike M, Fukayama M: MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation. Pathol Int 1999;49:968-973.
36. Hessman O, Lindberg D, Skogseid B, Carling T, Hellman P, Rastad J, Åkerström G, Westin G: Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Res 1998;58:377-379.
37. Hessman O, Lindberg D, Einrsson A, Lilhager P, Carling T, Grimelius L, Erikson B, Åkesron G, Westin G, Skogseid B: Genetic alterations on 3p, 11q13 and 18q in nonfamilial and MEN1-associated pancreatic endocrine tumors, Gene Chromosome Cancer 1999;26: 258-264.
38. Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E Jr, Sawicki M: Mutation of the MENIN gene in sporadic pancreatic endocrine tumors. Cancer Res 1998;58:4417-4420.
39. Goebel SU, Heppner C, Burns AL, Maerx SJ, Spiegel AM, Zhuang Z, Lubensky IA, Gibril F, Jensen RT, Serrano J: Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas. J Clin Endoerinol Metab 2000;85:116-123.
40. Mailman DM, Muscarella P, Schirmer WJ, Ellison EC, O'Dorisio TM, Prior TW: Identification of MENI mutations in sporadic enteropancreatic neuroendocrine tumors by analysis on paraffin-embedded tissue. Clin Chem 1999;45: 29-34.
41. Shan L, Nakamura Y, Nakamura M, Yokoi T, Tsujimoyo M, Arima R, Kameya T, Kakudo K: Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Lab Invest 1998;78:471-475.
42. Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw AL, Arnold A: A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest 1997;100:404-410.
43. Nikitforova MN, Nikiforov YE, Biddinger P, Gnepp DR, Grosemnbacher LA, Wajchenberg BL, Fagin JA, Cohen RM: Frequent loss of helerozygosity at chromosome 3p14.2-3P21 in human pancreatic islet cell tumors. Clin Endocrinol 1999;51:27-33.
44. Muscarella P, Melvin WS, Fisher WE, Foor JF, Ellisnon EC, Herman JG, Schirmer WJ, Hitchcock CL, DeYoung BR, Weghorst CM: Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: An analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Res 1998;58:237-240.
45. Lohmann DR, Funk A, Niedermeyer HP, Häupel S, Höfler H: Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:293-296.
46. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani NG: K-ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54: 1556-1560.
47. Hahn SA, Hoque AT, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE: Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 1996;56:490-494.
48. Bartsch D, Hahn SA, Danichevski KD, Ramaswamy A, Bastian D, Galendari H, Barth P, Schmiegel W, Simon B, Rolhmund M: Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene 1999;18: 2367-2371.
49. Roncalli M, Coggi G: Oncogenes and neuroendocrine tumours; in Polak JM (ed): Diagnostic Histopathology of Neuroendocrine Tumours. London, Churchill Livingstone, 1993, pp 41-66.
50. Chesa PG, Rettig WG, Melamed MR, Old LJ, Niman NL: Expression of p21 ras in normal and malignant human tissues: Lack of association with proliferation and malignancy. Proc Natl Acad Sci USA 1987;84:3234-3238.
51. Höfler H, Ruhri C, Putz B, Wirnsberger G, Hauser H: Oncogene expression in endocrine pancreatic tumors. Virchows Arch B Cell Pathol Incl Mol Pathol 1988;55:355-361.
52. Roncalli M, Springall DS, Varndell I, Gaitonde VV, Hamid Q, Ibrahim NBN, Grimelius L, Wilander E, Polak JM, Coggi G: Oncoprotein immunoreactivily in human endocrine tumours. J Pathol 1991;163:117-127.
53. Yashiro T, Fulton N, Hara H, Yasuda K, Montag A, Yashiro N, Straus F 2nd, Ito K, Aioshi Y, Kaplan EL: Comparison of mutations of ras oncogenc in human pancreatic exocrine and endocrine tumors. Surgery 1993;114:758-763.
54. Pavelic K, Hrascan R, Kapitanovic S, Vranes Z, Beliocza M, Kruslin B, Cabrijan T: Multiple genetic alterations in malignant metastatic insulinomas. J Pathol 1995;177:395-400.
55. Pavelic K, Hrascan R, Kapitanovic S, Vranes Z, Cabrijan T, Spaventi S, Korsic M, Krizanac S, Li YQ, Stambrock P, Gluckman JL, Pavelic ZP: Molecular genetics of malignant insulinoma. Anticancer Res 1996;16:1707-1717.
56. Rindi G, Luinetti O, Cornaggia M, Capella C, Solda E: Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study. Gastroenterology 1993;104:994-1006.
57. Bordi C, Falchetti A, Azzoni C, D'Adda T, Canavcse G, Guariglia A, Santini D, Tomassetti P, Brandi ML: Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type 1: Am J Surg Pathol 1997;21: 1075-1082.
58. Debelenko LV, Emmert-Buck MR, Zhuang Z, Epshteyn E, Moskaluk CA, Jensen RT, Liotta LA, Lubensky IA: The multiple endocrine neoplasia type 1 gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 1997;113:773-781.
59. Jakobovitz O, Nass D, DeMarco L, Barbosa AJA, Simoni FB, Rechavi G, Friedman E: Carcinoid tumor frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab 1996;81:3164-3167.
60. D'Adda T, Keller G, Bordi C, Holler H: Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Lab Invest 1999;79:671-677.
61. Higham AD, Bishop LA, Dimaline R, Blackmore CG, Dobbins AC, Varro A, Thompson DG, Doekray GJ: Mutations of Regla are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia. Gastroenterology 1999;116:1310-1318.
62. Rindi G, Alberizzi P, Candusso ME, LaRosa S, Capella C, Solcia E: Loss of heterozygosity for chromosome 17p. P53 gene, and chromosome 18q, DCC gene, in aggressive endocrine tumors of the stomach (abstract). Gastroenterology 1999;116:G2156.
63. D'Adda T, Candidus S, Denk H, Bordi C, Holler H: Gastric neuroendocrine neoplasms: Tumour clonality and malignancy-associated large X-chromosome deletions. J Pathol 1999; 189:394-401.
64. Vortmeyer AO, Lubensky IA, Merino MJ, Wang CY, Pham T, Furth EE, Zhuang Z: Concordance of genetic alteration in poorly differentiated neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst 1997;89:1448-1453.
65. Larsson K, Skogseid B, Öberg K, Nakamura Y, Nodrenskjöld M: Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332:85-87.